Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michael A. Fortunato currently holds 6,790 shares of BioStem Technologies, Inc. (BSEM), valued at approximately $0. This represents their equity stake as Chief Accounting Officer.
Based on SEC Form 4 filings, Michael A. Fortunato has been a net neutral trader of BSEM stock. They have purchased $0 and sold $0 worth of shares.
Michael A. Fortunato's most recent insider trade was on Aug 9, 2026, when they sold 970 shares at $0.00 per share.
Michael A. Fortunato serves as Chief Accounting Officer at BioStem Technologies, Inc. (BSEM). They have executed 2 insider transactions totaling $0 over their tenure at the company.
Michael A. Fortunato holds the position of Chief Accounting Officer at BioStem Technologies, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Michael A. Fortunato has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Michael A. Fortunato was on Aug 9, 2026, when they sold $0 worth of BSEM shares. This transaction involved 970 shares at N/A per share.
Michael A. Fortunato currently owns 6,790 shares of BioStem Technologies, Inc. (BSEM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michael A. Fortunato's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michael A. Fortunato has 2 Form 4 filings on record as an insider at BioStem Technologies, Inc..
Set alerts for Michael A. Fortunato and 40,000+ other insiders.